was read the article
array:24 [ "pii" => "S2341287917300716" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.04.008" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "2092" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2017;86:249-54" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1924 "formatos" => array:3 [ "EPUB" => 273 "HTML" => 1137 "PDF" => 514 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403316301680" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2016.04.001" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "2092" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2017;86:249-54" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5115 "formatos" => array:3 [ "EPUB" => 172 "HTML" => 4020 "PDF" => 923 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ORIGINAL</span>" "titulo" => "Tratamiento con hormona de crecimiento en pequeños para la edad gestacional en España" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "249" "paginaFinal" => "254" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Growth hormone treatment in small for gestational age children in Spain" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 807 "Ancho" => 1588 "Tamanyo" => 51485 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Evolución de la talla (DE).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Manuel Rial Rodríguez, Antonio de Arriba Muñoz, Jordi Bosch Muñoz, Paloma Cabanas Rodríguez, Ramón Cañete Estrada, Ignacio Díez López, María Magdalena Hawkins Solís, María José Martínez-Aedo Ollero, Ana Cristina Rodríguez Dehli, Lourdes Ibáñez Toda" "autores" => array:11 [ 0 => array:2 [ "nombre" => "José Manuel" "apellidos" => "Rial Rodríguez" ] 1 => array:2 [ "nombre" => "Antonio" "apellidos" => "de Arriba Muñoz" ] 2 => array:2 [ "nombre" => "Jordi" "apellidos" => "Bosch Muñoz" ] 3 => array:2 [ "nombre" => "Paloma" "apellidos" => "Cabanas Rodríguez" ] 4 => array:2 [ "nombre" => "Ramón" "apellidos" => "Cañete Estrada" ] 5 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Díez López" ] 6 => array:2 [ "nombre" => "María Magdalena" "apellidos" => "Hawkins Solís" ] 7 => array:2 [ "nombre" => "María José" "apellidos" => "Martínez-Aedo Ollero" ] 8 => array:2 [ "nombre" => "Ana Cristina" "apellidos" => "Rodríguez Dehli" ] 9 => array:2 [ "nombre" => "Lourdes" "apellidos" => "Ibáñez Toda" ] 10 => array:1 [ "colaborador" => "en representación del Grupo de trabajo para el estudio del paciente pequeño para la edad gestacional (PEG) de la Sociedad Española de Endocrinología Pediátrica (SEEP)" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287917300716" "doi" => "10.1016/j.anpede.2016.04.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287917300716?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316301680?idApp=UINPBA00005H" "url" => "/16954033/0000008600000005/v1_201704260013/S1695403316301680/v1_201704260013/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S234128791730073X" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.05.006" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "2119" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2017;86:255-63" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1888 "formatos" => array:3 [ "EPUB" => 273 "HTML" => 1091 "PDF" => 524 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Spanish patients with central hypoventilation syndrome included in the European Registry. The 2015 data" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "255" "paginaFinal" => "263" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pacientes españoles con síndrome de hipoventilación central incluidos en el Registro europeo. Datos del 2015" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1039 "Ancho" => 1648 "Tamanyo" => 46048 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Ventilatory support modalities used (bars) and number of patients supported by each modality at home discharge and as of December 2015.</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">NIV, noninvasive ventilation with mask; PNP, phrenic nerve pacing; TRACH, tracheostomy.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Angeles García Teresa, Raquel Porto Abal, Silvia Rodríguez Torres, Diego García Urabayen, Silvia García Martínez, Ha Trang, Angel Campos Barros" "autores" => array:8 [ 0 => array:2 [ "nombre" => "María Angeles" "apellidos" => "García Teresa" ] 1 => array:2 [ "nombre" => "Raquel" "apellidos" => "Porto Abal" ] 2 => array:2 [ "nombre" => "Silvia" "apellidos" => "Rodríguez Torres" ] 3 => array:2 [ "nombre" => "Diego" "apellidos" => "García Urabayen" ] 4 => array:2 [ "nombre" => "Silvia" "apellidos" => "García Martínez" ] 5 => array:2 [ "nombre" => "Ha" "apellidos" => "Trang" ] 6 => array:2 [ "nombre" => "Angel" "apellidos" => "Campos Barros" ] 7 => array:1 [ "colaborador" => "Grupo Español de Trabajo del SHCC" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403316302016" "doi" => "10.1016/j.anpedi.2016.05.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316302016?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128791730073X?idApp=UINPBA00005H" "url" => "/23412879/0000008600000005/v1_201704260029/S234128791730073X/v1_201704260029/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287917300686" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.05.005" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "2111" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2017;86:240-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2083 "formatos" => array:3 [ "EPUB" => 280 "HTML" => 1295 "PDF" => 508 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Effects of growth hormone treatment on anthropometrics, metabolic risk, and body composition variables in small for gestational age patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "240" "paginaFinal" => "248" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Modificaciones en variables antropométricas, analíticas de riesgo metabólico y composición corporal en pequeños para la edad gestacional en tratamiento con hormona de crecimiento" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1847 "Ancho" => 1614 "Tamanyo" => 95194 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Changes in height (SD) relative to genetic potential (SD) during followup.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Esther Aurensanz Clemente, Pilar Samper Villagrasa, Ariadna Ayerza Casas, Pablo Ruiz Frontera, Olga Bueno Lozano, Luis Alberto Moreno Aznar, Gloria Bueno Lozano" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Esther" "apellidos" => "Aurensanz Clemente" ] 1 => array:2 [ "nombre" => "Pilar" "apellidos" => "Samper Villagrasa" ] 2 => array:2 [ "nombre" => "Ariadna" "apellidos" => "Ayerza Casas" ] 3 => array:2 [ "nombre" => "Pablo" "apellidos" => "Ruiz Frontera" ] 4 => array:2 [ "nombre" => "Olga" "apellidos" => "Bueno Lozano" ] 5 => array:2 [ "nombre" => "Luis Alberto" "apellidos" => "Moreno Aznar" ] 6 => array:2 [ "nombre" => "Gloria" "apellidos" => "Bueno Lozano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403316301898" "doi" => "10.1016/j.anpedi.2016.05.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316301898?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287917300686?idApp=UINPBA00005H" "url" => "/23412879/0000008600000005/v1_201704260029/S2341287917300686/v1_201704260029/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Growth hormone treatment in small for gestational age children in Spain" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "249" "paginaFinal" => "254" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José Manuel Rial Rodríguez, Antonio de Arriba Muñoz, Jordi Bosch Muñoz, Paloma Cabanas Rodríguez, Ramón Cañete Estrada, Ignacio Díez López, María Magdalena Hawkins Solís, María José Martínez-Aedo Ollero, Ana Cristina Rodríguez Dehli, Lourdes Ibáñez Toda" "autores" => array:11 [ 0 => array:4 [ "nombre" => "José Manuel" "apellidos" => "Rial Rodríguez" "email" => array:1 [ 0 => "jmrial53@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Antonio" "apellidos" => "de Arriba Muñoz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Jordi" "apellidos" => "Bosch Muñoz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Paloma" "apellidos" => "Cabanas Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Ramón" "apellidos" => "Cañete Estrada" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "Ignacio" "apellidos" => "Díez López" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "María Magdalena" "apellidos" => "Hawkins Solís" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "María José" "apellidos" => "Martínez-Aedo Ollero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "Ana Cristina" "apellidos" => "Rodríguez Dehli" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 9 => array:3 [ "nombre" => "Lourdes" "apellidos" => "Ibáñez Toda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">j</span>" "identificador" => "aff0050" ] ] ] 10 => array:1 [ "colaborador" => "On behalf of Grupo de trabajo para el estudio del paciente pequeño para la edad gestacional (PEG) de la Sociedad Española de Endocrinología Pediátrica (SEEP)" ] ] "afiliaciones" => array:10 [ 0 => array:3 [ "entidad" => "Unidad de Endocrinología, Servicio de Pediatría, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Hospital Universitario Miguel Servet, Zaragoza, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Hospital Universitari Arnau de Vilanova, Universidad de Lleida, Lleida, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Crecimiento y Adolescencia, Departamento de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Hospital Universitario Reina Sofía, Córdoba, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, OSI-Araba, Hospital Universitario Araba, Departamento de Pediatría, Universidad del País Vasco, Vitoria, Álava, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Pediatría, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Hospital Materno-Infantil Carlos Haya, Málaga, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Unidad de Endocrinología Pediátrica, Hospital San Agustín, Avilés, Asturias, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Unidad de Endocrinología, Hospital Sant Joan de Déu, Universidad de Barcelona, Barcelona, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "j" "identificador" => "aff0050" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento con hormona de crecimiento en pequeños para la edad gestacional en España" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 807 "Ancho" => 1588 "Tamanyo" => 55004 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Changes in stature (SD).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The term small for gestational age comprehends all newborns whose birth weight or birth crown-heel length is 2 sd below the mean for their sex and gestational age based on a reference population.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">1</span></a> Since 2003, when the European Medicines Agency approved the use of recombinant human growth hormone (rhGH) for the treatment of children small for gestational age (SGA) or with intrauterine growth restriction (IUGR) without postnatal catchup growth, a large number of patients have received this treatment in Spain. However, we do not know the exact number of patients, their geographical distribution, the age at treatment initiation, the clinical response and the potential adverse effects that have been observed. Much of this information can be found in the registers of the advisory committees that authorise rhGH treatment in the different autonomous communities (regions) of Spain. In order to obtain an objective understanding of the characteristics of the use of rhGH in children born SGA in Spain, we collected the data from these registers in several autonomous communities as a preliminary phase for a nationwide study.</p><p id="par0010" class="elsevierStylePara elsevierViewall">After analysing the data and correcting potential errors in the calculated values, we compared the results with those of domestic and international studies on the use of rhGH for the treatment of SGA children.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><p id="par0015" class="elsevierStylePara elsevierViewall">We collected all the data contained in the registers of the advisory committees that regulate the distribution of rhGH by the Department of Public Health of the different autonomous communities on the patients in whom treatment was authorised, with the exception of confidential personal information. The collected data included parental heights, gestational age, birth weight and birth length. We also recorded the age, weight, height, pubertal stage of development and growth velocity of patients at the time of treatment initiation and in subsequent checkups, as well as the prescribed doses of rhGH and the final height achieved by those that completed treatment during the period under study. We also recorded the age at menarche in female patients.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We assessed auxologic measurements using the charts of the Estudio Colaborativo Español 2008<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">2</span></a> and pubertal development by means of Tanner scale.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">3</span></a> We summarised the data as means and standard deviations (SDs). We used the IBM SPSS 19.0 software for Windows for the statistical analysis. We conducted two-tailed Student's <span class="elsevierStyleItalic">t</span> tests and paired-sample <span class="elsevierStyleItalic">t</span> tests. We defined statistical significance for all the analysed variables as a <span class="elsevierStyleItalic">p</span>-value of less than 0.05 for a 95% confidence interval.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Results</span><p id="par0025" class="elsevierStylePara elsevierViewall">We analysed the treatments (number) registered from 2004 to 2014 in the autonomous communities of Aragón (76), Basque Country (87), Navarra (56), Catalonia (525), Cantabria (69) and Galicia (161). We obtained valid data for a total of 974 patients (48% male). These patients amounted to approximately 21% of the total rhGH treatments authorised in those autonomous communities. Five percent of the patients were born from multiple gestations and 23% born preterm, and the gestational age for the overall sample was 38<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3 weeks.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The mean birth weight was −2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1 SD and the mean birth length was −2.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9 SD.</p><p id="par0035" class="elsevierStylePara elsevierViewall">At birth, the length of 81% of the patients was at least 2 SDs below the mean and the weight of 54% at least 2 SDs below the mean, and both were at least 2 SDs below the mean in 42% of the patients.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In 27% of the patients, the target heights ([father's height<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>mother's height<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>13]/2) were at least 2 SDs below the mean. The mean target height was −1.5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1 SD.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Patients started receiving treatment with rhGH at an age of 7.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.8 years. During the period under study, the age at treatment initiation did not change significantly in the more recent patients.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The height at treatment initiation was −3.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 SD, and the baseline growth velocity was −1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.5 SD. The stage of pubertal development at initiation of treatment was Tanner I in 89%, Tanner II in 7% and Tanner III in 2%.</p><p id="par0055" class="elsevierStylePara elsevierViewall">The initial dose of rhGH was 35<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6<span class="elsevierStyleHsp" style=""></span>μg/kg/day, and we found no significant changes at follow up or depending of the year in which treatment was initiated; the initial dose was also independent of age and stage of pubertal development at initiation. All patients received uninterrupted treatment.</p><p id="par0060" class="elsevierStylePara elsevierViewall">The height gains associated with treatment corresponded to 0.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2 SDs in the first year, and 1.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 SDs in the first two years. Approximately 30% of patients achieved height <span class="elsevierStyleItalic">z</span>-scores greater than −2 SD in the first year of treatment, and another 60% of patients achieved them in the second year (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). In the fifth year of treatment, heights had increased by 2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.9 SDs compared to baseline. Growth velocity increased by 3.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.3 SDs compared to the year before treatment initiation. We did not find statistically significant differences in treatment response based on gestational age.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">Fourteen percent of patients exhibited a response in the first year of treatment that was more than 2 SDs below the mean for the sample, corresponding to height gains of less than 0.3 SD, which can serve as the threshold for defining nonresponders. Up to 24% had height gains of less than 0.5 SD and 55% had growth velocity increases of less than 3<span class="elsevierStyleHsp" style=""></span>cm/year.</p><p id="par0070" class="elsevierStylePara elsevierViewall">The response in the first year of treatment was negatively correlated with initial height (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.40) and the age at initiation of treatment (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.36), and positively correlated with the rhGH dose (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.24), associations that were statistically significant (<span class="elsevierStyleItalic">P<span class="elsevierStyleHsp" style=""></span><</span><span class="elsevierStyleHsp" style=""></span>.05).</p><p id="par0075" class="elsevierStylePara elsevierViewall">Eight percent of the patients reached their final heights during the follow-up, corresponding to a mean of −1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7 SD, very similar to the target height, with a difference of −0.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1 SD.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The age at menarche, available for 13% of female patients, was 13.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2 years.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Discussion</span><p id="par0085" class="elsevierStylePara elsevierViewall">Several studies conducted abroad on the use of rhGH in SGA children with no postnatal catchup growth support its efficacy and safety.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">4,5</span></a> Following its approval by EMA, the Spanish Ministry of Health introduced its indication under the category of intrauterine growth restriction. In the past few years, several publications have reported the outcomes of treatment in different case series that included patients from different hospitals.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">6–10</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">However, until now we had no data on the number of SGA patients treated with rhGH and their proportion compared to other indications for the use of rhGH, their geographical distribution, and the details concerning their followup. Our study analysed data for all SGA children treated with rhGH in a specific geographical area that comprised six autonomous communities in the north of Spain, a preliminary phase in a nationwide study, and included 974 patients that received this treatment in the 2004–2014 period. Our study has the limitations imposed by the source of the data, as the registers do not collect exhaustive information on obstetric factors, comorbidities, side effects or adherence to treatment. However, given the considerable number of patients included and the absence of selection bias (they were treated in different hospitals and received rhGH made by different manufacturers), our study is representative of the use of rhGH for the treatment of SGA children (IUGR) in Spain.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Our results reveal a characteristic profile in the patients in whom treatment with rhGH is authorised: target height below the mean, smaller birth lengths compared to birth weights, and in nearly 25%, preterm. This profile could be used to identify SGA children whose growth should be monitored more closely in the early years of life. Other series have also described target heights of approximately 1 SD below the mean,<a class="elsevierStyleCrossRefs" href="#bib0230"><span class="elsevierStyleSup">11,12</span></a> but in our series 27% of the target heights were at least 2 SDs below the mean, suggesting a marked genetic component in the short stature of this group of patients.</p><p id="par0100" class="elsevierStylePara elsevierViewall">Children born preterm, who amount to 5% to 9% of births in Europe,<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">13</span></a> were disproportionally represented in our sample, amounting to 23% of the patients, although this proportion was similar to the one found by another study conducted in Spain, the DATAC study, in which 27% of patients had been born preterm.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">10</span></a> The response to treatment of children born preterm was comparable to that of children born at term.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">14</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Although treatment is approved by the EMA starting at age 4 years, the mean age at initiation in our patients was 7.2 years, a delay that did not improve during the period under study. Other studies conducted in Spain reported similar ages.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">6,7,9,10</span></a> We hypothesise that the reason for this is that the practise of referring all SGA children that do not experience catchup growth in the early years to paediatric endocrinology services is not yet widespread.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The response to rhGH, expressed as an increase in height SDs, is greater the younger the age at initiation, a finding that was confirmed in our study with a strong negative correlation between age and height gain in the first year of treatment. The findings of other series are similar.<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">8,11,12</span></a> An adequate follow-up of SGA children from birth would allow initiation of treatment and the normalisation of stature at earlier ages.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">15</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">We found that patients had uniformly received a mean dose of 35<span class="elsevierStyleHsp" style=""></span>μg/kg/day, which did not change during the follow-up nor based on age or the time to initiation of treatment. Although the dose adjustment during puberty remains controversial,<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">16,17</span></a> we also found no evidence of dose adjustment based on the stage of pubertal development. On the other hand, different doses of rhGH do not lead to significantly different outcomes in the long term.<a class="elsevierStyleCrossRefs" href="#bib0265"><span class="elsevierStyleSup">18,19</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">Our study corroborated that treatment with rhGH in children SGA is generally efficacious, both in the early stages and in patients reaching their final heights, with the latter achieving values within the range of the target height, a goal that has not always been achieved in previous studies.<a class="elsevierStyleCrossRefs" href="#bib0265"><span class="elsevierStyleSup">18,20–22</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">However, there was variability in the response to treatment, with 14% of nonrespondents, which in our study was defined as a height increase of less than 0.3 SD in the first year, and up to 24% if we were to apply the criteria of height gain less than 0.5 SD.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">23</span></a> Some studies have defined inadequate response as an increase of less than 3<span class="elsevierStyleHsp" style=""></span>cm in the growth velocity.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">24</span></a> Based on this criterion, 55% of the patients in our sample would be categorised as nonrespondents. In any case, the mean response values in our patients are consistent with those reported in other studies,<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">25</span></a> both in Spain (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>) and internationally (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Higher doses were used in the series of Carrascosa et al.,<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">7</span></a> Argente et al.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">8</span></a> and Boguszewski et al.,<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">26</span></a> and the last two included younger patients. The meta-analysis conducted by Maiorana and Cianfarani,<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">27</span></a> which included several European studies, found that patients failed to achieve their target heights, despite the use of higher doses compared to our study, possibly due to initiation of treatment at older ages. The largest series published to date, in the context of the KIGS study and funded by Pfizer<span class="elsevierStyleSup">®</span>, with 900 patients and a mean dose of 40<span class="elsevierStyleHsp" style=""></span>μg/kg/day, found a height gain of 0.7 SD in the first year, as did our study, but had final heights around −2 SD.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">11</span></a> In the series of Ridder et al.,<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">28</span></a> the final height was far below the target height, despite the use of doses of up to 67<span class="elsevierStyleHsp" style=""></span>μg/kg/day. The height catchup observed in our sample was similar to that observed in patients treated for growth hormone deficiency.<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">25,29</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall">The response observed in the first year of treatment is a predictor of final height.<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">30,31</span></a> In our sample, the determinants of the initial response were the age at initiation of treatment, the initial height and the dose of rhGH, which was consistent with other studies.<a class="elsevierStyleCrossRefs" href="#bib0315"><span class="elsevierStyleSup">28,31</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Although we did not have detailed information on the onset of puberty, the age at menarche in 13% of the female patients was 13 years. While treatment with rhGH does not seem to affect the onset and development of puberty in general,<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">32</span></a> a longer followup period is required for confirmation. The SGA population enters puberty at an age close to the mean for the general population, although girls with low birth weights that experience rapid weight and height catchup tend to reach puberty at earlier ages<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">33</span></a> and may present with pronounced adrenarche and hyperandrogenism associated with hyperinsulinism.<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">34</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">The analysis of the data obtained from the official registers of the autonomous communities did not allow us to draw conclusions regarding the safety of treatment with rhGH in SGA patients. However, the evidence in the existing literature consistently suggests that there are no significant risks—at least in the intermediate term—with frequent elevation of blood insulin levels that resolves spontaneously.<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">1,4,5,35</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conclusions</span><p id="par0145" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">(1)</span><p id="par0150" class="elsevierStylePara elsevierViewall">We present a study based on a population of SGA children managed with rhGH in Spain, with no bias from the use of a specific brand of recombinant hormone, treated in several different hospitals following the criteria of the EMA with the approval the advisory committees of the specific autonomous communities. It includes cases from the initial authorisation for its use in IUGR/SGA to the recent past.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">(2)</span><p id="par0155" class="elsevierStylePara elsevierViewall">The sample of 974 patients was the largest studied to date, and comparable to those of international studies that included patients from different countries. We believe that this study is representative of the use of rhGH for the treatment of IUGR/SGA in Spain.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">(3)</span><p id="par0160" class="elsevierStylePara elsevierViewall">We found that most patients responded well to treatment from the first year, achieving final heights that were close to the genetic potential or target height. Twenty-four percent of the patients responded poorly, with height gains of less than 0.5 SD in the first year.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">(4)</span><p id="par0165" class="elsevierStylePara elsevierViewall">The information pertaining to adverse effects and pubertal development was not recorded in the database with adequate accuracy, and should be investigated with different methods.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">(5)</span><p id="par0170" class="elsevierStylePara elsevierViewall">The data underscore the importance of starting treatment with rhGH early with the purpose of achieving normal heights in children born SGA. Small for gestational age children whose length was more affected than weight at birth, whose parents have short statures or born preterm should be monitored closely in the first three years of life to initiate treatment promptly if they do not exhibit spontaneous catch-up growth.</p></li></ul></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conflicts of interests</span><p id="par0175" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres833063" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec828986" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres833064" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec828987" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Methods" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Conclusions" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Conflicts of interests" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2016-02-15" "fechaAceptado" => "2016-04-12" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec828986" "palabras" => array:4 [ 0 => "Small for gestational age" 1 => "Growth hormone" 2 => "Treatment outcome" 3 => "Public hospitals" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec828987" "palabras" => array:4 [ 0 => "Pequeño para la edad gestacional" 1 => "Hormona de crecimiento" 2 => "Respuesta terapéutica" 3 => "Hospitales públicos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Since its approval by the European Medicines Agency, a great number of patients born small for gestational date have received recombinant growth hormone treatment in Spain. The aim of this study is to analyse its outcome in the setting of ordinary clinical practice.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Information was gathered from the registers of the assessment boards that authorise all growth hormone treatments prescribed in public hospitals in six autonomic communities (regions).</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Valid data from 974 patients was obtained. All of them complied with criteria established by the European Medicines Agency. Patients in the sample were smaller in length than weight at birth, with their median target height being below 1 standard deviation (SD), and 23% of them had been delivered prematurely. Treatment was started at 7.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.8 years (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD). The mean patient height at start was −3.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 SD. They gained 0.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2 SD in the first year, and 1.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 SD after two years. Final height was attained by 8% of the sample, reaching −1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7 SD.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">These results are similar to other Spanish and international published studies, and are representative of the current practice in Spain.</p><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Despite treatment being started at a late age, adequate growth is observed in the short term and in the final height. Up to a 24% of patients show a poor response in the first year.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducción</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Desde su aprobación por la Agencia Europea del Medicamento, el tratamiento con hormona de crecimiento recombinante ha sido empleado en un gran número de pacientes nacidos pequeños para la edad gestacional en España. El propósito de este estudio es conocer objetivamente los resultados del mismo en la práctica habitual.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Se ha recogido información procedente de los registros existentes en los comités asesores que autorizan dichos tratamientos en los hospitales públicos de 6 comunidades autónomas.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Se han obtenido datos válidos de 974 pacientes. Todos ellos cumplían los criterios exigidos por la Agencia Europea del Medicamento. Los pacientes que recibieron el tratamiento se caracterizaron por tener la longitud al nacer más afectada que el peso, talla diana inferior a –1 desviación estándar (DE) y un 23% con antecedentes de prematuridad. La talla al iniciar el tratamiento fue de −3,1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0,8 DE (media<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>DE) y la edad de comienzo 7,2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2,8 años. La ganancia de talla en el primer año fue de 0,7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0,2 DE, y de 1,2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0,8 DE hasta los 2 años. La talla final, alcanzada por un 8% de pacientes, fue de –1,4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0,7 DE.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Los resultados concuerdan con las series nacionales e internacionales publicadas y son representativos de la práctica habitual en nuestro país.</p><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Se constata un inicio tardío del tratamiento, observándose, sin embargo, un adecuado crecimiento, tanto a corto plazo como en la talla final. En el primer año se identifica un 24% de pacientes con respuesta deficiente.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as: Rial Rodríguez JM, de Arriba Muñoz A, Bosch Muñoz J, Cabanas Rodríguez P, Cañete Estrada R, Díez López I, et al. Tratamiento con hormona de crecimiento en pequeños para la edad gestacional en España. An Pediatr (Barc). 2017;86:249–254.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 807 "Ancho" => 1588 "Tamanyo" => 55004 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Changes in stature (SD).</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">STUDY \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Luzuriaga Tomás et al.,<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">6</span></a> 2003 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Carrascosa et al.,<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">7</span></a> 2006 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Argente et al.,<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">8</span></a> 2007 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">López Siguero et al.,<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">9</span></a> 2013 \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Number of patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">42 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">68 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">76 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">147 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Target height<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−0.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age at initiation (years)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Baseline height<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2.5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Height at 1 year<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−1.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δ Height in 1st year (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose (μg/kg/day) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1403214.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Values expressed as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Studies conducted in Spain.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Values are expressed as means.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Study \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">KIGS,<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">11</span></a> 2007 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">De Ridder et al.,<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">28</span></a> 2008 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kriström et al.,<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">30</span></a> 2009 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Boguszewski et al.,<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">26</span></a> 2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Maiorana and Cianfarani<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">27</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Current series \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Number of patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">900 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">150 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">367 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">156 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">391 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">974 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Target height (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−0.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−0.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−0.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age at initiation (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Baseline height (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−3.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−3.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−3.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−3.1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Height at 1 year (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δ Height in 1st year (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose (μg/kg/day) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">33/67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">33 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">33–67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">35 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final height (<span class="elsevierStyleItalic">z</span>-score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−2.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">−1.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1403213.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">International studies.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:35 [ 0 => array:3 [ "identificador" => "bib0180" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International Small for Gestational Age Advisory Board International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P.A. Lee" 1 => "S.D. Chernausek" 2 => "A.C. Hokken-Koelega" 3 => "P. Czernichow" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2003" "volumen" => "111" "paginaInicial" => "1253" "paginaFinal" => "1261" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12777538" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0185" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio transversal español de crecimiento 2008. Parte II: valores de talla, peso e índice de masa corporal desde el nacimiento a la talla adulta" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Carrascosa Lezcano" 1 => "J.M. Fernández García" 2 => "C. Fernández Ramos" 3 => "A. Ferrández Longás" 4 => "J.P. López-Siguero" 5 => "E. Sánchez González" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr (Barc)" "fecha" => "2008" "volumen" => "68" "paginaInicial" => "544" "paginaFinal" => "551" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0190" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variations in pattern of pubertal changes in girls" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "W.A. Marshall" 1 => "J.M. Tanner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "1969" "volumen" => "44" "paginaInicial" => "291" "paginaFinal" => "303" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/5785179" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0195" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Hokken-Koelega" 1 => "Y. van Pareren" 2 => "N. Arends" 3 => "V. Boonstra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000080518" "Revista" => array:7 [ "tituloSerie" => "Horm Res" "fecha" => "2004" "volumen" => "62" "numero" => "Suppl. 3" "paginaInicial" => "149" "paginaFinal" => "154" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15539818" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0200" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and efficacy of growth hormone treatment in small for gestational age children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Poduval" 1 => "P. Saenger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MED.0b013e3283081911" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Endocrinol Diabetes Obes" "fecha" => "2008" "volumen" => "15" "paginaInicial" => "376" "paginaFinal" => "382" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18594280" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0205" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La hormona de crecimiento (GH) es eficaz y segura en el tratamiento de los niños con talla baja y antecedentes de retraso de crecimiento intrauterino con independencia de la secreción de GH" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Luzuriaga Tomás" 1 => "M. Oyarzabal Irigoyen" 2 => "J. Bel i Comos" 3 => "M.L. Granada Ybern" 4 => "A. Tejerina Puente" 5 => "M. Chueca Guindulain" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Inv Clin Farm" "fecha" => "2003" "paginaInicial" => "13" "paginaFinal" => "23" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0210" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The d3/fl-Growth Hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66<span class="elsevierStyleHsp" style=""></span>mcg/kg per Day) or the spontaneous growth in short non-GH deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 spanish patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Carrascosa" 1 => "C. Esteban" 2 => "R. Espadero" 3 => "R. Fernández-Cancio" 4 => "P. Andaluz" 5 => "M. Clemente" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-0685" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2006" "volumen" => "91" "paginaInicial" => "3281" "paginaFinal" => "3286" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16804042" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0215" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth: results of a multi-center, controlled, randomized, open clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Argente" 1 => "R. Gracia" 2 => "L. Ibáñez" 3 => "A. Oliver" 4 => "E. Borrajo" 5 => "A. Vela" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-0078" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "3095" "paginaFinal" => "3101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17536000" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0220" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eficacia y seguridad del tratamiento con hormona de crecimiento en niños pequeños para su edad gestacional: Análisis intermedio a 3 años. Estudio multicéntrico" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.P. López Siguero" 1 => "M.J. Martínez Aedo" 2 => "J.A. Bermúdez" 3 => "N. Cabrinety" 4 => "J.L. Lechuga" 5 => "A. Gutiérrez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Rev Esp Endocrinol Pediatr" "fecha" => "2013" "volumen" => "4" "paginaInicial" => "175" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0225" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The DATAC study: a new growth database description of the epidemiology diagnosis and therapeutic attitude in a group of Spanish children with short stature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.D. Rodríguez Arnao" 1 => "A. Rodríguez Sánchez" 2 => "C. García-Rey" 3 => "F. Arroyo Díez" 4 => "R. Cañete Estrada" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/jpem-2013-0394" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Endocrinol Metab" "fecha" => "2014" "volumen" => "27" "paginaInicial" => "1201" "paginaFinal" => "1208" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25210749" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0230" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "KIGS 20 years: children born small for gestational age" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D. Dunger" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Growth hormone therapy in pediatrics. 20 years of KIGS" "paginaInicial" => "400" "paginaFinal" => "406" "serieFecha" => "2007" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0235" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Final height in short children born small for gestational age treated with growth hormone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Dahlgren" 1 => "K. Albertsson Wikland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1203/01.PDR.0000148716.71231.81" "Revista" => array:6 [ "tituloSerie" => "Pediatr Res" "fecha" => "2005" "volumen" => "57" "paginaInicial" => "216" "paginaFinal" => "222" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15585685" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0240" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology and causes of preterm birth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.L. Goldenberg" 1 => "J.F. Culhane" 2 => "J.D. Iams" 3 => "R. Romero" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60074-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2008" "volumen" => "371" "paginaInicial" => "75" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18177778" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0245" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth hormone treatment in short children born prematurely — data from KIGS" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.C.S. Boguszewski" 1 => "H. Karlsson" 2 => "H.A. Wollmann" 3 => "P. Wilton" 4 => "J. Dahlgren" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2010-1829" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2011" "volumen" => "96" "paginaInicial" => "1687" "paginaFinal" => "1694" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21430029" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0250" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early diagnosis and treatment referral of children born small for gestational age without catch-up growth are critical for optimal growth outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.P. Houk" 1 => "P.A. Lee" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1687-9856-2012-11" "Revista" => array:5 [ "tituloSerie" => "Int J Pediatr Endocrinol" "fecha" => "2012" "volumen" => "2012" "paginaInicial" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22559301" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0255" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spontaneous growth hormone secretion increases during puberty in normal girls and boys" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.R. Rose" 1 => "G. Municchi" 2 => "K.M. Barnes" 3 => "G.A. Kamp" 4 => "M.M. Uriarte" 5 => "J.L. Ross" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem-73-2-428" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1991" "volumen" => "73" "paginaInicial" => "428" "paginaFinal" => "435" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1856268" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0260" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An analysis of the clinical and cost effectiveness of growth hormone replacement therapy before and during puberty: should we increase the dose?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.R. Howard" 1 => "G.E. Butler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000346687" "Revista" => array:6 [ "tituloSerie" => "Horm Res Paediatr" "fecha" => "2013" "volumen" => "79" "paginaInicial" => "75" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23406656" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0265" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. De Zegher" 1 => "A. Hokken-Koelega" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2004-1934" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2005" "volumen" => "115" "paginaInicial" => "e458" "paginaFinal" => "e462" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15805349" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0270" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y. Van Pareren" 1 => "P. Mulder" 2 => "M. Houdijk" 3 => "M. Jansen" 4 => "M. Reeser" 5 => "A. Hokken-Koelega" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2002-021172" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2003" "volumen" => "88" "paginaInicial" => "3584" "paginaFinal" => "3590" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12915640" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0275" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adult height of prepubertal short children born small for gestational age treated with GH" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "on behalf of the 0908 Lilly Study Group" "etal" => false "autores" => array:4 [ 0 => "M. Rosilio" 1 => "J.C. Carel" 2 => "E. Ecosse" 3 => "J.L. Chaussain" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/eje.1.01916" "Revista" => array:6 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "2005" "volumen" => "152" "paginaInicial" => "835" "paginaFinal" => "843" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15941922" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0280" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Final height of short subjects of low birth weight with and without growth hormone treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Zucchini" 1 => "E. Cacciari" 2 => "A. Balsamo" 3 => "A. Cicognani" 4 => "D. Tassinari" 5 => "E. Barbieri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "2001" "volumen" => "84" "paginaInicial" => "340" "paginaFinal" => "343" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11259236" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0285" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Coutant" 1 => "J.C. Carel" 2 => "M. Letrait" 3 => "C. Bouvattier" 4 => "P. Chatelain" 5 => "J. Coste" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.83.4.4750" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1998" "volumen" => "83" "paginaInicial" => "1070" "paginaFinal" => "1074" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9543119" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0290" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Height velocity targets from the National Cooperative Growth Study for first year growth hormone responses in short children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B. Bakker" 1 => "J. Frane" 2 => "H. Anhalt" 3 => "B. Lippe" 4 => "R.G. Rosenfeld" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-1581" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2008" "volumen" => "93" "paginaInicial" => "352" "paginaFinal" => "357" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18000092" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0295" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of different definitions of growth response in short prepubertal children treated with growth hormone" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Bang" 1 => "R. Bjerknes" 2 => "J. Dahlgren" 3 => "L. Dunkel" 4 => "J. Gustafsson" 5 => "A. Juul" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000322878" "Revista" => array:6 [ "tituloSerie" => "Horm Res Paediatr" "fecha" => "2011" "volumen" => "75" "paginaInicial" => "335" "paginaFinal" => "345" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21228552" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0300" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observational studies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.A. Lee" 1 => "L. Sävendahl" 2 => "I. Oliver" 3 => "M. Tauber" 4 => "O. Blankenstein" 5 => "J. Ross" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1687-9856-2012-22" "Revista" => array:5 [ "tituloSerie" => "Int J Pediatr Endocrinol" "fecha" => "2012" "volumen" => "2012" "paginaInicial" => "22" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22788856" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0305" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Three-year growth response to growth hormone treatment in very young children born small for gestational age — data from KIGS" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.C.S. Boguszewski" 1 => "A. Lindberg" 2 => "H.A. Wollmann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2013-4117" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2014" "volumen" => "99" "paginaInicial" => "2683" "paginaFinal" => "2688" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24758180" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0310" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of growth hormone therapy on adult height of children born small for gestational age" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Maiorana" 1 => "S. Cianfarani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2009-0293" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2009" "volumen" => "124" "paginaInicial" => "e519" "paginaFinal" => "e531" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19706577" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0315" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction model for adult height of SGA children at start of growth hormone treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.A.J. De Ridder" 1 => "T.H. Stijnen" 2 => "A.C.S. Hokken-Koelega" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-1381" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2008" "volumen" => "93" "paginaInicial" => "477" "paginaFinal" => "483" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18000093" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0320" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.P. August" 1 => "J.R. Julius" 2 => "S.L. Blethen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "1998" "volumen" => "102" "paginaInicial" => "512" "paginaFinal" => "516" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9685455" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0325" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B. Kriström" 1 => "J. Dahlgren" 2 => "A. Niklasson" 3 => "A.F.M. Nierop" 4 => "K. Albertsson-Wikland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1472-6947-9-1" "Revista" => array:5 [ "tituloSerie" => "BMC Med Inform Decis Mak" "fecha" => "2009" "volumen" => "9" "paginaInicial" => "1" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19138407" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0330" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.B. Ranke" 1 => "A. Lindberg" 2 => "C.T. Cowell" 3 => "K. Albertsson-Wikland" 4 => "E.O. Reiter" 5 => "P. Wilton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2002-020867" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2003" "volumen" => "88" "paginaInicial" => "125" "paginaFinal" => "131" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12519840" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0335" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Puberty in growth hormone-treated children born small for gestational age (SGA)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "V. Boonstra" 1 => "Y. van Pareren" 2 => "P. Mulder" 3 => "A. Hokken-Koelega" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2003-030512" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2003" "volumen" => "88" "paginaInicial" => "5753" "paginaFinal" => "5758" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14671164" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0340" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Persson" 1 => "F. Ahlsson" 2 => "U. Ewald" 3 => "T. Tuvemo" 4 => "M. Qingyuan" 5 => "D. von Rosen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Epidemiol" "fecha" => "1999" "volumen" => "150" "paginaInicial" => "747" "paginaFinal" => "755" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10512428" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0345" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Ibañez" 1 => "N. Potau" 2 => "I. Francois" 3 => "F. de Zegher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.83.10.5205" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1998" "volumen" => "83" "paginaInicial" => "3558" "paginaFinal" => "3562" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9768664" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0350" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of the child born small for gestational age through infancy to adulthood: a consensus statement of the international societies of pediatric endocrinology and the Growth Hormone Research Society" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.E. Clayton" 1 => "S. Cianfarani" 2 => "P. Czernichow" 3 => "G. Johannsson" 4 => "R. Rapaport" 5 => "A. Rogol" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-2017" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "804" "paginaFinal" => "810" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17200164" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:3 [ "titulo" => "Acknowledgments" "texto" => "<p id="par0180" class="elsevierStylePara elsevierViewall">We thank the prescribing paediatricians in Aragón, Cantabria, Catalonia, Basque Country, Galicia and Navarra, as well as the advisory boards and committees on growth hormone of those autonomous communities, for providing the data analysed in the study.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000008600000005/v1_201704260029/S2341287917300716/v1_201704260029/en/main.assets" "Apartado" => array:4 [ "identificador" => "26005" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000008600000005/v1_201704260029/S2341287917300716/v1_201704260029/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287917300716?idApp=UINPBA00005H" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 14 | 9 | 23 |
2024 October | 86 | 40 | 126 |
2024 September | 62 | 37 | 99 |
2024 August | 97 | 62 | 159 |
2024 July | 89 | 28 | 117 |
2024 June | 111 | 28 | 139 |
2024 May | 99 | 26 | 125 |
2024 April | 85 | 43 | 128 |
2024 March | 74 | 24 | 98 |
2024 February | 79 | 31 | 110 |
2024 January | 89 | 30 | 119 |
2023 December | 90 | 23 | 113 |
2023 November | 89 | 30 | 119 |
2023 October | 93 | 24 | 117 |
2023 September | 86 | 32 | 118 |
2023 August | 69 | 20 | 89 |
2023 July | 56 | 24 | 80 |
2023 June | 61 | 32 | 93 |
2023 May | 58 | 19 | 77 |
2023 April | 47 | 17 | 64 |
2023 March | 74 | 22 | 96 |
2023 February | 60 | 15 | 75 |
2023 January | 46 | 48 | 94 |
2022 December | 81 | 35 | 116 |
2022 November | 91 | 28 | 119 |
2022 October | 73 | 38 | 111 |
2022 September | 60 | 36 | 96 |
2022 August | 66 | 46 | 112 |
2022 July | 49 | 45 | 94 |
2022 June | 35 | 49 | 84 |
2022 May | 53 | 40 | 93 |
2022 April | 61 | 49 | 110 |
2022 March | 76 | 64 | 140 |
2022 February | 66 | 45 | 111 |
2022 January | 85 | 51 | 136 |
2021 December | 73 | 38 | 111 |
2021 November | 79 | 51 | 130 |
2021 October | 104 | 87 | 191 |
2021 September | 56 | 40 | 96 |
2021 August | 44 | 57 | 101 |
2021 July | 43 | 42 | 85 |
2021 June | 52 | 49 | 101 |
2021 May | 52 | 55 | 107 |
2021 April | 104 | 67 | 171 |
2021 March | 43 | 28 | 71 |
2021 February | 27 | 20 | 47 |
2021 January | 29 | 26 | 55 |
2020 December | 40 | 23 | 63 |
2020 November | 32 | 15 | 47 |
2020 October | 22 | 21 | 43 |
2020 September | 50 | 22 | 72 |
2020 August | 26 | 13 | 39 |
2020 July | 27 | 18 | 45 |
2020 June | 28 | 6 | 34 |
2020 May | 26 | 13 | 39 |
2020 April | 22 | 18 | 40 |
2020 March | 33 | 19 | 52 |
2020 February | 19 | 15 | 34 |
2020 January | 18 | 14 | 32 |
2019 December | 55 | 18 | 73 |
2019 November | 24 | 8 | 32 |
2019 October | 40 | 22 | 62 |
2019 September | 43 | 14 | 57 |
2019 August | 67 | 18 | 85 |
2019 July | 37 | 22 | 59 |
2019 June | 31 | 19 | 50 |
2019 May | 46 | 31 | 77 |
2019 April | 33 | 19 | 52 |
2019 March | 31 | 22 | 53 |
2019 February | 28 | 11 | 39 |
2019 January | 33 | 23 | 56 |
2018 December | 43 | 19 | 62 |
2018 November | 90 | 26 | 116 |
2018 October | 152 | 13 | 165 |
2018 September | 55 | 14 | 69 |
2018 August | 1 | 0 | 1 |
2018 June | 8 | 0 | 8 |
2018 May | 13 | 0 | 13 |
2018 April | 18 | 0 | 18 |
2018 March | 17 | 0 | 17 |
2018 February | 6 | 0 | 6 |
2018 January | 12 | 0 | 12 |
2017 December | 20 | 0 | 20 |
2017 November | 20 | 0 | 20 |
2017 October | 22 | 0 | 22 |
2017 September | 17 | 0 | 17 |
2017 August | 14 | 0 | 14 |
2017 July | 22 | 0 | 22 |
2017 June | 35 | 8 | 43 |
2017 May | 51 | 44 | 95 |
2017 April | 24 | 145 | 169 |